Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2010-09-17 Capital/Financing Update
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
S-1 Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the securities being registered, risk factors, use of proceeds, selling stockholders, business description, and other disclosures typical of a registration statement. It is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to securities registration and offering. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full registration statement, not just an announcement or notice.
2010-09-17 English
424B3 Filing
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is explicitly described as a quarterly report for the period ended June 30, 2010. It contains detailed unaudited condensed consolidated financial statements, including balance sheets, statements of operations, changes in stockholders' equity, and cash flows. It also includes management's discussion and analysis, risk factors, legal proceedings, and other information typical of a quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2010-08-23 English
10-Q Filing
Interim / Quarterly Report Q2 2010
2010-08-13 English
4 Filing
Director's Dealing
2010-08-10 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 24, 2010. It includes disclosures about unregistered sales of equity securities (warrant exercises), voting results from the Annual Meeting of Stockholders, and other board-related events such as the election of directors. The presence of voting results from the Annual Meeting and the detailed vote counts strongly indicate this is a Declaration of Voting Results & Voting Rights Announcement. The document is not a full annual report or financial statement, but a current report focusing on specific events and voting outcomes. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length (4919 characters) and content support this classification with high confidence.
2010-05-27 English
SC 13D/A Filing
Major Shareholding Notification
2010-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.